Stocks making the biggest moves in the premarket: Tesla, Apple, AstraZeneca and more

for a phase three trial of a lung cancer treatment.

While the drug compared well to a competitor on one endpoint, the data for overall survival was "not mature" and pointed toward to the results being not statistically significant, AstraZeneca said in a press release. The trial will continue, according to the company.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the moveTesla and AstraZeneca stock head in opposite directions.
Source: MarketWatch - 🏆 3. / 97 Read more »

Wall Street analysts reveal their top ideas for the second half, including this red-hot solar nameWall Street analysts named their top second half stocks this week.
Source: CNBC - 🏆 12. / 72 Read more »

Study Explains Why Everyone Is Adopting Tesla's Supercharging Network | CarscoopsA new customer satisfaction study by J.D. Power sheds light into why more and more companies are adopting Tesla's charging standard car auto cars
Source: Carscoop - 🏆 306. / 63 Read more »

Recession will take shine off stocks' AI-fueled rally in H2: HSBCUS stocks face a painful rest of 2023 with a recession set to take the shine off the AI-fueled rally, HSBC says
Source: BusinessInsider - 🏆 729. / 51 Read more »